DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
Fredun received one-year contract worth Rs. 65 crores from a Southeast Asian country for Pharma exports
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
The company plans to expand its portfolio in regulated markets aggressively
In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020
The pandemic has provided tailwinds in terms of access to rural healthcare and India’s emergence as a vaccine powerhouse
Subscribe To Our Newsletter & Stay Updated